RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

RTI In The Media

Former Biogen exec launches RTP startup

March 28, 2023 - Triangle Inno
RTI In The Media

Triangle biotech startup aims to slow disease progression with RTI compounds

March 23, 2023 - WRAL TechWire
RTI In The Media

RTP’s APIE Therapeutics Signs Pact to Develop RTI International Heart, Lung Drug Prospects

August 28, 2020 - NC Biotechnology Center
RTI In The Media

RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease

August 26, 2020 - WRAL TechWire
RTI In The Media

Research Triangle Park Home to Breakthrough in Combating Drug-Resistant Tuberculosis

November 12, 2019 - CBS 17
RTI In The Media

Treatment for Post-Traumatic Stress Disorder Shows Promise, New RTI International Study Finds

November 07, 2019 - WRAL TechWire
RTI In The Media

Former Greensboro Girl Scout, Grimsley Grad Helps Find Cure for Deadly TB Strain

September 07, 2019 - Greensboro News & Record
RTI In The Media

Breakthrough in Fight Against Multi-Resistant Tuberculosis

September 02, 2019 - Forbes
RTI In The Media

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

August 15, 2019 - Medscape
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 15, 2019 - Yahoo News UK
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 14, 2019 - The Telegraph
RTI In The Media

After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis

August 14, 2019 - Triangle Business Journal
RTI In The Media

FDA Approves Treatment Targeting Drug-Resistant Tuberculosis Backed by RTI Scientist

August 14, 2019 - WRAL TechWire